American International Group’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,503
| Closed | -$202K | – | 843 |
|
|
2024
Q1 | $202K | Sell |
11,503
-100
| -0.9% | -$1.76K | ﹤0.01% | 2145 |
|
|
2023
Q4 | $161K | Sell |
11,603
-46
| -0.4% | -$637 | ﹤0.01% | 2289 |
|
|
2023
Q3 | $159K | Buy |
11,649
+414
| +4% | +$5.66K | ﹤0.01% | 2247 |
|
|
2023
Q2 | $229K | Buy |
+11,235
| New | +$229K | ﹤0.01% | 2088 |
|
|
2021
Q2 | – | Sell |
-1,116
| Closed | -$38 | – | 3161 |
|
|
2021
Q1 | $38 | Buy |
1,116
+3
| +0.3% | – | ﹤0.01% | 3041 |
|
|
2020
Q4 | $98 | Buy |
1,113
+374
| +51% | +$33 | ﹤0.01% | 2670 |
|
|
2020
Q3 | $60K | Sell |
739
-17
| -2% | -$1.38K | ﹤0.01% | 2808 |
|
|
2020
Q2 | $84K | Buy |
+756
| New | +$84K | ﹤0.01% | 2630 |
|